Iyar Mazar
- Oncology
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Economics and Econometrics
- Pediatrics, Perinatology and Child Health
- Co-authors
- Alan L. ShieldsMeaghan KroheDaniel EekFarrah PompilusYanni HaoDenise GlobeCatherine FoleyJonathan Stokes
- Topics
- Economic and Financial Impacts of Cancer (5 papers)Childhood Cancer Survivors' Quality of Life (4 papers)Health Systems, Economic Evaluations, Quality of Life (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaBloodClinical Therapeutics
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Iyar Mazar
19 papers receiving 306 citations
Peers
Comparison fields: 5 of 83
- Oncology 93
- Molecular Biology 66
- Pulmonary and Respiratory Medicine 49
- Economics and Econometrics 44
- Pediatrics, Perinatology and Child Health 37
Countries citing papers authored by Iyar Mazar
This map shows the geographic impact of Iyar Mazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iyar Mazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iyar Mazar more than expected).
Fields of papers citing papers by Iyar Mazar
This network shows the impact of papers produced by Iyar Mazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iyar Mazar. The network helps show where Iyar Mazar may publish in the future.
Co-authorship network of co-authors of Iyar Mazar
This figure shows the co-authorship network connecting the top 25 collaborators of Iyar Mazar. A scholar is included among the top collaborators of Iyar Mazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iyar Mazar. Iyar Mazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 8 | |
| 12 | 180 | |
| 13 | 5 | |
| 14 | 19 | |
| 15 | 1 | |
| 16 | 18 | |
| 17 | Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges. | 11 |
| 18 | 4 | |
| 19 | 14 | |
| 20 | 10 |
About Iyar Mazar
Iyar Mazar is a scholar working on Clinical Biochemistry, Statistics and Probability and Economics and Econometrics, having authored 20 papers that have together received 313 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Family Practice (37 citations), Geriatrics and Gerontology (14 citations) and Oncology (93 citations). Iyar Mazar has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Alan L. Shields, Meaghan Krohe, Daniel Eek, Farrah Pompilus, Yanni Hao, Denise Globe, Catherine Foley, Jonathan Stokes, Andrew Yaworsky and Roger E. Lamoureux. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.